Skip to main content

Table 3 Complications (n = 118)

From: Maxillofacial free flap surgery outcomes in critical care: a single-center investigation looking for clues to improvement

Variables

Value

Surgical

69 (58.5)

ā€ƒWound healing

33 (28.0)

ā€ƒWound infection

21 (17.8)

ā€ƒHemorrhage

17 (14.4)

ā€ƒPartial necrosis

13 (11.0)

ā€ƒOrostoma

11 (9.3)

ā€ƒVenous thrombosis

10 (8.5)

ā€ƒPostoperative tracheotomy

8 (6.8)

ā€ƒTotal necrosis

8 (6.8)

ā€ƒArterial thrombosis

5 (4.2)

Surgical reintervention

36 (30.5)

Medical

47 (39.8)

ā€ƒPneumonia

30 (25.4)

ā€ƒMetabolic

8 (6.8)

ā€ƒNeurological

6 (5.1)

ā€ƒCardiovascular

5 (4.2)

ā€ƒExtra-pulmonary sepsis

5 (4.2)

ā€ƒAtrial fibrillation

4 (3.4)

ā€ƒAcute lung edema

3 (2.5)

ā€ƒAbdominal

3 (2.5)

ā€ƒRespiratory (pneumonia excluded)

2 (1.7)

ā€ƒPulmonary embolism

2 (1.7)

Infectious

47 (39.8)

Any complication

84 (71.2)

Major complication

39 (33.1)

Prolonged ICU LOS

55 (46.6)

ICU readmission

12 (10.2)

Mortality

Ā 

ā€ƒDuring hospitalization

1 (0.9)

ā€ƒ1ā€‰year (n = 116)

14 (12.1)

  1. Categorical variables are presented as n (%) and continuous variables as mean Ā± SD
  2. ICU intensive care unit, LOS length of stay
  3. Due to missing data, the number of patients included is presented as (n =) after each variable
  4. Wound healing and wound infection problems include both donor and recipient sites while other surgical complications were observed only at the recipient site
  5. Metabolic complications include significant ionic and glycemic disturbances